FY 2021 Appropriations Provides FDA Healthy Boost – Plus More COVID-19 Funds

 
• By Derrick Gingery

Budget authority increase for medical product safety is coupled with additional funds for coronavirus countermeasure development and advanced manufacturing.

WASHINGTON, DC - MAY 20, 2019: US SENATE COMMITTEE ON THE APPROPRIATIONS HEARING ROOM SD 124 - entrance sign
The FY 2021 omnibus appropriations bills includes increases for CDER and CDRH, as well as separate funds for coronavirus vaccine development and supply chain monitoring. • Source: File photo

More from US FDA

More from Agency Leadership